logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On February 25, XD INC (02400) spent 4.8488 million Hong Kong dollars to repurchase 63,000 shares.

date
18:47 25/02/2026
avatar
GMT Eight
Heartbeat Company (02400) announced on February 25, 2026 that it would spend HKD 4.8488 million to repurchase 63,000 shares.
XD INC (02400) announced on February 25, 2026 that it will spend 4.8488 million Hong Kong dollars to repurchase 63,000 shares.
Related Articles
HK Stock
Hong Kong Dragon CHINAPROPERTIES (06968) achieved a contract sales amount of approximately 201.4 million yuan in January, a year-on-year decrease of 55.24%.
HK Stock
SMART FISH (00139) acquired a total of 10.05 million shares of CMBC CAPITAL.
New stock news: Hanfang Pharmaceutical submits application to Hong Kong Stock Exchange. Flagship product is compound Huangbai liquid solution.
Hong Kong Dragon CHINAPROPERTIES (06968) achieved a contract sales amount of approximately 201.4 million yuan in January, a year-on-year decrease of 55.24%.
HK Stock
SMART FISH (00139) acquired a total of 10.05 million shares of CMBC CAPITAL.
HK Stock
New stock news: Hanfang Pharmaceutical submits application to Hong Kong Stock Exchange. Flagship product is compound Huangbai liquid solution.
RECOMMEND
Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
icon
25/02/2026
Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
icon
25/02/2026
AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
icon
25/02/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.